BREAST ATYPICAL HYPERPLASIA
Clinical trials for BREAST ATYPICAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BREAST ATYPICAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for BREAST ATYPICAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can fish oil boost Tamoxifen's power to prevent breast cancer?
Prevention Recruiting nowThis study tests whether adding high-dose omega-3 fatty acids to low-dose tamoxifen can lower breast cancer risk more than tamoxifen alone. It includes 66 overweight or obese postmenopausal women at increased risk for breast cancer. The goal is to see if the combination improves …
Matched conditions: BREAST ATYPICAL HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
New drug acolbifene takes on tamoxifen in breast cancer prevention trial
Prevention Recruiting nowThis study tests whether acolbifene or a low dose of tamoxifen can reduce breast cancer risk in premenopausal women at high risk. Both drugs block estrogen from reaching breast cells. Researchers will measure changes in breast tissue, blood, and mammograms over six months in 80 w…
Matched conditions: BREAST ATYPICAL HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC